Compliance to Antihypertensive Treatment and Causes of Partial or Poor Compliance in Patients Attending Ali-Kamal Consultation Center in Suliamania
Keywords:
Hypertension, Compliance, Unemployed, Follow-up, private pharmacyAbstract
Background and objectives: Hypertension is common chronic disease, its prevalence increases with age, the goal of treating hypertension is to control blood pressure below the target level (140/90 mm Hg). Poor or non compliance is one of the biggest and modifiable obstacles in controlling high blood pressure.
Method: Descriptive study was conducted on a 418 hypertensive patients at Ali Kamal consultation clinics in Suliamania city, from 3rd May 2008 to 2nd July 2008. During interview questionnaires were used to evaluate patient's compliance. SPSS version 13 was used for analysis.
Results: In studied sample (30.4%) were males and (69.6%) were females, the mean age±SD (58±10). Compliance to antihypertensive treatments was (58%), Fair compliance (30%), and poor compliance (12%). Significant association (P<0.05) were found between good compliance and older age, Unemployed 353(84.4%), longer duration of hypertension 221(52.9%), doing follow up in private clinics 37(69.8%), Depending on both Governmental and private pharmacy to get medications 206(52.4%), knowledge of patient and home blood pressure checking 90(73.2%). While gender, illiterate 263(62.9), medium economic state 294 (70.3), positive family history of hypertension 250(59.8), No previous hospital admission 261(62.4) and number of prescribed drugs do not affect compliance (P>0.05).
Conclusions: Younger age, poor hypertension awareness and employment adversely affect compliance to antihypertensive medication. Regular blood pressure checking increases compliance, while numbers of drugs and gender not affect compliance rate.
Metrics
References
Aram V, George L, Henry R, William C. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension. 2003; 42:1206-1252
2003 World Health Organization- International Society of Hypertension (ISH) Statement on Management of Hypertension. J hypertens 2003; 21:1983-1992.
Oscar A, Suzanne O. Essential Hypertension. Circulation. 2000; 101:329-332.
EInkster M, Donnan P, MacDonald T, Adherence to antihypertensive medication and association with patient and practice factors. Hum Hypertens J. 2006; 20: 295–7.
World Health Organization. Chapter XIII Hypertension in Adherence to Long-Term therapies-Evidence for Action. 2003; 129–36. Available at www.who.int visited 10-5-2008
Mant J, McManus R. Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control. J Hum Hypertens. 2006 ;20: 551–3.
Wagner J, Justice A, Chesney M. Patient and provider reported adherence toward a clinically useful approach to measuring antiretroviral adherence. J Clin Epidemiol 2001; 54 :(1):91-98.
Kearney P, Whelton M, Reynolds K. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365: 217–23.
Barber N. Should we consider non-compliance a medical error? Qual Saf Health Care 2002; 11: 81–4.
Donnan P, MacDonald T. Adherence to antihypertensive medication and association with patient and practice factors. J Hum Hypertens.2006; 20: 295–7.
Youssef R, Moubarak I. Patterns and determinants of treatment compliance among hypertensive patients. East Mediterr Health J. 2002; 8:4–5.
E Jokisalo. Compliance and patient-perceived problems in the treatment of hypertension. Pharmaceutical Sciences. 2005; 82:28-42.
Al-Sowielem L,Elzubiber A. Compliance and Knowledge of hypertensive patients attending PHC centers in Al-Khobar in Saudi Arabia. East Mediterr J.1998: 4; 301-7.
Mark A, Benjamin W. Tassell V, Joanne L. Medication Nonadherence: An Unrecognized Cardiovascular Risk Factor.MedGenMed. 2007; 9(3): 58
Al-Yahya A, Amal M, Al-Ghareeb H. Comparison of Compliance versus Non-Compliance to Anti-hypertensive Agents in Primary Health Care - An Area Based Study. Kuwait Medical Journal 2006, 38 (1): 28-32
Shaw E, Anderson JG, Maloney M. Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm. 1995; 30: 201-07.
Conlin P, Gerth W, Fox J. Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes. Clin Ther 2001; 23: 1999–2010.
Degli L, Degli E, Valpiani G. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther 2002; 24: 1347-57.
Kwame O, Lloyd M, Jacob P. Unaffordable drug price: the major cause of non-compliance with hypertens. J Pharmrceut Sci, 2004; 7(3):350-2.
Almas A, Hameed A, Ahmed B, Islam M. Compliance to antihypertensive therapy. JCPSP, 2006; 16: 23–6.
Nudrat N, Juanita H, Nish C. Hypertension Research Group. Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomized controlled trial. BMJ 2007; 335:1030–6.
Bull S, Hu X, Hunkeler E. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002; 288:1403–9.
Downloads
Published
How to Cite
Issue
Section
License
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).
